Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients with Resectable Pancreatic and Colorectal Cancer.
作者信息
Rossi Alexander J, Khan Tahsin M, Hong Hanna, Lesinski Gregory B, Wu Christina, Hernandez Jonathan M
机构信息
Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA.
出版信息
Ann Surg Oncol. 2021 Aug;28(8):4098-4099. doi: 10.1245/s10434-021-10111-0. Epub 2021 May 13.
PMID:33987757
Abstract
摘要
Zotero 插件